Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification
scientific article
Author/s
author: Sai-Hong Ignatius Ou, Ravi Salgia, Yung-Jue Bang, Kristin Bergethon, A John Iafrate, Keith D Wilner, Eunice L Kwak, D Ross Camidge, Jeffrey W Clark, Benjamin J Solomon, James G Christensen, Robert G. Maki
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.